The store will not work correctly when cookies are disabled.
4-(4-(tert-Butyl)benzamido)-6-chloronicotinic acid
ID: ALA4754068
PubChem CID: 162654125
Max Phase: Preclinical
Molecular Formula: C17H17ClN2O3
Molecular Weight: 332.79
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ccc(C(=O)Nc2cc(Cl)ncc2C(=O)O)cc1
Standard InChI: InChI=1S/C17H17ClN2O3/c1-17(2,3)11-6-4-10(5-7-11)15(21)20-13-8-14(18)19-9-12(13)16(22)23/h4-9H,1-3H3,(H,22,23)(H,19,20,21)
Standard InChI Key: AYIBPZCBXBEWFO-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
34.0235 -20.9002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.0223 -21.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7304 -22.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4400 -21.7193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4372 -20.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7286 -20.4914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7302 -22.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0223 -23.3544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4378 -23.3547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.1484 -22.1268 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8554 -21.7171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5638 -22.1246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8541 -20.8999 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.5604 -22.9402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2680 -23.3476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9760 -22.9379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9721 -22.1164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2640 -21.7127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6849 -23.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7261 -19.6742 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
39.6873 -24.1616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3914 -22.9338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3891 -23.7522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
7 8 1 0
7 9 2 0
4 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
16 19 1 0
6 20 1 0
19 21 1 0
19 22 1 0
19 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 332.79 | Molecular Weight (Monoisotopic): 332.0928 | AlogP: 3.98 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.29 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.94 | CX Basic pKa: 1.19 | CX LogP: 4.52 | CX LogD: 1.33 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.83 | Np Likeness Score: -1.37 |
References
1. Khalifa MM,Martorelli Di Genova B,McAlpine SG,Gallego-Lopez GM,Stevenson DM,Rozema SD,Monaghan NP,Morris JC,Knoll LJ,Golden JE. (2020) Dual-Stage Picolinic Acid-Derived Inhibitors of Toxoplasma gondii., 11 (12): [PMID:33335660] [10.1021/acsmedchemlett.0c00267] |